Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL338P is a pseudogene derived from the 7SL RNA gene, located on human chromosome 9. 7SL pseudogenes are typically truncated, non-coding copies dispersed throughout the human genome, formed by reverse transcription of functional 7SL RNA into DNA. While functional 7SL RNA is a key component of the signal recognition particle required for co- and post-translational protein targeting within the cell, pseudogene copies such as RN7SL338P do not encode active RNA and are generally not expressed at significant levels. Pseudogenes may have potential regulatory roles as non-coding RNAs, such as acting as competitive endogenous RNAs, but there is no established function or disease relevance attributed specifically to RN7SL338P. It is not considered a therapeutic target, and its name and annotation are correct as a pseudogene in current databases.
Null (no mechanisms of action for drugs targeting RN7SL338P)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 338, pseudogene (RN7SL338P).